These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2558696)

  • 21. Hepatitis B infection among patients receiving chronic hemodialysis at the Royal Medical Services in Jordan.
    Al Hijazat M; Ajlouni YM
    Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):260-7. PubMed ID: 18310881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis and HIV infection during haemodialysis.
    Saha D; Agarwal SK
    J Indian Med Assoc; 2001 Apr; 99(4):194-9, 203, 213. PubMed ID: 11666025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outbreaks of infection and/or pyrogenic reactions in dialysis patients.
    Roth VR; Jarvis WR
    Semin Dial; 2000; 13(2):92-6. PubMed ID: 10795111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus infection in Haemodialysis Centres from Santa Catarina State, Southern Brazil. Predictive risk factors for infection and molecular epidemiology.
    Carrilho FJ; Moraes CR; Pinho JR; Mello IM; Bertolini DA; Lemos MF; Moreira RC; Bassit LC; Cardoso RA; Ribeiro-dos-Santos G; Da Silva LC
    BMC Public Health; 2004 Apr; 4():13. PubMed ID: 15113436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occult HBV infection status among chronic hepatitis C and hemodialysis patients in Northeastern Egypt: regional and national overview.
    Mandour M; Nemr N; Shehata A; Kishk R; Badran D; Hawass N
    Rev Soc Bras Med Trop; 2015; 48(3):258-64. PubMed ID: 26108002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National surveillance of dialysis-associated diseases in the United States, 1997.
    Tokars JI; Miller ER; Alter MJ; Arduino MJ
    Semin Dial; 2000; 13(2):75-85. PubMed ID: 10795109
    [No Abstract]   [Full Text] [Related]  

  • 29. Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country.
    Otedo AE; Mc'Ligeyo SO; Okoth FA; Kayima JK
    S Afr Med J; 2003 May; 93(5):380-4. PubMed ID: 12830604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staff knowledge, adherence to infection control recommendations and seroconversion rates in hemodialysis centers in Khartoum.
    Elamin S; Salih LO; Mohammed SI; Ali SE; Mohammed NF; Hassan EH; Ahmed MA; Rahamtalla AA; Abu-Aisha H
    Arab J Nephrol Transplant; 2011 Jan; 4(1):13-9. PubMed ID: 21469590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occult hepatitis B virus infection in a cohort of Egyptian chronic hemodialysis patients.
    Elgohry I; Elbanna A; Hashad D
    Clin Lab; 2012; 58(9-10):1057-61. PubMed ID: 23163124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 1990s perspective of hepatitis C, human immunodeficiency virus, and tuberculosis infections in dialysis patients.
    Murthy BV; Pereira BJ
    Semin Nephrol; 1997 Jul; 17(4):346-63. PubMed ID: 9241719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt.
    Helaly GF; El Ghazzawi EF; Shawky SM; Farag FM
    J Infect Public Health; 2015; 8(6):562-9. PubMed ID: 26026236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B prevention strategies among pediatric hemodialysis centers.
    Toma M; Challapalli M
    Infect Control Hosp Epidemiol; 2001 Feb; 22(2):113-5. PubMed ID: 11232873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B and C status among health care workers in the five main hospitals in eastern Libya.
    Elzouki AN; Elgamay SM; Zorgani A; Elahmer O
    J Infect Public Health; 2014; 7(6):534-41. PubMed ID: 25151657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsin.
    Steketee RW; Ziarnik ME; Davis JP
    Am J Epidemiol; 1988 Apr; 127(4):772-82. PubMed ID: 2965510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].
    Fabrizi F; Bisegna S; Mangano S; Alongi G; Colucci P; Finazzi S; De Vecchi AF; Ponticelli C
    G Ital Nefrol; 2002; 19(2):149-54. PubMed ID: 12195413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transmission of hepatitis B virus in dialysis units: a systematic review of reports on outbreaks.
    Fabrizi F; Dixit V; Messa P; Martin P
    Int J Artif Organs; 2015 Jan; 38(1):1-7. PubMed ID: 25633894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of hepatitis B, hepatitis delta, and human immunodeficiency virus infections in Omani patients with renal diseases.
    Aghanashinikar PN; al-Dhahry SH; al-Marhuby HA; Buhl MR; Daar AS; Al-Hasani MK
    Transplant Proc; 1992 Oct; 24(5):1913-4. PubMed ID: 1412910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.